MedTrace Logo

CABP2 Patient Registry and Natural History Study

NCT06680934 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-01-27

No results posted yet for this study

Summary

This registry is designed to collect comprehensive information about the molecular genetic diagnoses and clinical information of individuals with CABP2-associated hearing impairment to support a natural history study.

Conditions

Interventions

DIAGNOSTIC_TEST

Molecular genetic testing and audiometry

Genetic testing and audiometry are the interventions of interest

Sponsors & Collaborators

  • University Medical Center Goettingen

    lead OTHER

Principal Investigators

  • Tobias Moser, MD · University Medical Center Goettingen

  • Bernd Wollnik, MD · University Medical Center Goettingen

  • Nicola Strenzke, MD · University Medical Center Goettingen

  • Barbara Vona, PhD · University Medical Center Goettingen

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-16
Primary Completion
2049-08-16
Completion
2049-08-16

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06680934 on ClinicalTrials.gov